Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 6.29x is in line with its 2-year average of 5.79x, near the low end of its 2-year range (1.27x–32.90x).
22.64% below its 12-month average of 8.13x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 2.83x.
INTEREST COVERAGE RATIO
6.29x
INTEREST COVERAGE RATIO AVG TTM
8.13x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-22.64%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.88x
median of 82 covered companies
CURRENT VS SECTOR MEDIAN
-8.64%
vs the sector median at left
Solventum Corporation
Market Cap
$15.45B
Interest Coverage Ratio
6.29x
TTM Avg
8.13x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.19B
Interest Coverage Ratio
N/A
TTM Avg
393.08x
3Y Avg
892.58x
5Y Avg
554.26x
Market Cap
$14.59B
Interest Coverage Ratio
N/A
TTM Avg
19.12x
3Y Avg
19.12x
5Y Avg
19.12x
Market Cap
$13.58B
Interest Coverage Ratio
3.87x
TTM Avg
4.06x
3Y Avg
4.92x
5Y Avg
8.88x
Market Cap
$13.13B
Interest Coverage Ratio
4.74x
TTM Avg
3.27x
3Y Avg
5.51x
5Y Avg
5.84x
Market Cap
$17.99B
Interest Coverage Ratio
4.65x
TTM Avg
5.28x
3Y Avg
5.28x
5Y Avg
4.27x
Market Cap
$12.57B
Interest Coverage Ratio
144.35x
TTM Avg
102.58x
3Y Avg
62.73x
5Y Avg
62.73x
Market Cap
$12.45B
Interest Coverage Ratio
-1.06x
TTM Avg
0.71x
3Y Avg
2.65x
5Y Avg
6.89x
Market Cap
$12.11B
Interest Coverage Ratio
8.55x
TTM Avg
7.42x
3Y Avg
7.61x
5Y Avg
6.89x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $15.45B | 6.29x | 8.13x | N/A | N/A |
| Medpace Holdings, Inc. (MEDP)vs › | $16.19B | N/A | 393.08x | 892.58x | 554.26x |
| Exelixis, Inc. (EXEL)vs › | $14.59B | N/A | 19.12x | 19.12x | 19.12x |
| Revvity, Inc. (RVTY)vs › | $13.58B | 3.87x | 4.06x | 4.92x | 8.88x |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.13B | 4.74x | 3.27x | 5.51x | 5.84x |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $17.99B | 4.65x | 5.28x | 5.28x | 4.27x |
| Penumbra, Inc. (PEN)vs › | $12.57B | 144.35x | 102.58x | 62.73x | 62.73x |
| Baxter International Inc. (BAX)vs › | $12.45B | -1.06x | 0.71x | 2.65x | 6.89x |
| Encompass Health Corporation (EHC)vs › | $12.11B | 8.55x | 7.42x | 7.61x | 6.89x |
| Viatris Inc. (VTRS)vs › | $18.99B | -5.65x | 0.68x | 1.36x | 1.37x |
Interest Coverage
6.3x
Debt/Equity
1.10
Current Ratio
1.02
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 2.83x |
| 2026-03-31 | 1.31x |
| 2025-12-31 | 32.90x |
| 2025-09-30 | 1.54x |
| 2025-06-30 | 2.08x |
| 2025-03-31 | 1.46x |
| 2024-12-31 | 1.27x |
| 2024-09-30 | 2.57x |
| 2024-06-30 | 2.14x |
| 2024-03-31 | 9.77x |
